The reproductive tract microbiome, which consists of the microorganisms in the female reproductive system, plays a crucial role in influencing fertility and the success of in vitro fertilization (IVF) treatments. Research suggests that the microbiome in the uterus, cervix, fallopian tubes, and vagina can impact various reproductive processes.

One key mechanism through which the reproductive tract microbiome influences fertility is by maintaining a balanced vaginal microbiota composition. Imbalances in the vaginal microbiome, such as bacterial vaginosis (BV), have been linked to infertility by affecting sperm function, embryo implantation, and pregnancy maintenance. Certain beneficial bacteria, such as Lactobacillus species, are associated with a healthier reproductive tract environment and have been shown to support successful conception and pregnancy.

In the context of IVF treatments, the reproductive tract microbiome has been found to influence the success rates of fertility procedures. Studies have demonstrated that the presence of specific bacteria in the reproductive tract can impact the outcome of IVF cycles. For example, the composition of the endometrial microbiome has been associated with implantation success and live birth rates following IVF. A dysbiotic microbiome in the uterus may lead to inflammation or unfavorable conditions for embryo implantation, thereby affecting the chances of a successful pregnancy.

Researchers are exploring the potential of modulating the reproductive tract microbiome to improve fertility outcomes, including enhancing the success of IVF treatments. Strategies such as probiotic supplementation, prebiotics, or targeted antibiotics have